nach oben

Rheumatology International

Erschienen in:

01.04.2016 | Review Article - Pathogenic Review

Gut inflammation and microbiome in spondyloarthritis

verfasst von: Jayakanthan Kabeerdoss, Pulukool Sandhya, Debashish Danda

Erschienen in: Rheumatology International | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

Spondyloarthritis (SpA) is chronic inflammatory disease involving joints and the spine. Bowel inflammation is common in SpA, which may be classified as acute or chronic. Chronic gut inflammation is most common in SpA patients with axial involvement as compared to those presenting with peripheral involvement alone. The pathogenesis of gut inflammation in SpA could be explained by two factors—over-activation of immunological cells and altered gut microbiome. This is exemplified by SpA animal models, namely HLA-B27-expressing transgenic animals and SKG mice models. Immunological mechanisms include homing of activated T cells from gut into synovium, excess pro-inflammatory cytokines secretion by immune cells such as IL-23 and genetic variations in immunological genes. The evidence for role of gut microbiome in SpA is gradually emerging. Recently, metagenomic study of gut microbiome by sequencing of microbial nucleic acids has enabled identification of new microbial taxa and their functions in gut of patients with SpA. In SpA, the gut microbiome could emerge as diagnostic and prognostic marker of disease. Modulation of gut microbiome is slated to have therapeutic potential as well.

Davis JC, Mease PJ (2008) Insights into the pathology and treatment of spondyloarthritis: from the bench to the clinic. Semin Arthritis Rheum 38:83–100. doi:10.1016/j.semarthrit.2007.10.007 PubMedCrossRef

Tse SML, Laxer RM (2012) New advances in juvenile spondyloarthritis. Nat Rev Rheumatol 8:269–279. doi:10.1038/nrrheum.2012.37 PubMedCrossRef

Mielants H, De Vos M, Cuvelier C, Veys EM (1996) The role of gut inflammation in the pathogenesis of spondyloarthropathies. Acta Clin Belg 51:340–349PubMed

Mielants H, Veys EM, Cuvelier C et al (1995) The evolution of spondyloarthropathies in relation to gut histology. II. Histological aspects. J Rheumatol 22:2273–2278PubMed

de Vlam K, Mielants H, Cuvelier C et al (2000) Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association. J Rheumatol 27:2860–2865PubMed

De Vos M, Mielants H, Cuvelier C et al (1996) Long-term evolution of gut inflammation in patients with spondyloarthropathy. Gastroenterology 110:1696–1703PubMedCrossRef

Scarpa R, Manguso F, D’Arienzo A et al (2000) Microscopic inflammatory changes in colon of patients with both active psoriasis and psoriatic arthritis without bowel symptoms. J Rheumatol 27:1241–1246PubMed

Schatteman L, Mielants H, Veys EM et al (1995) Gut inflammation in psoriatic arthritis: a prospective ileocolonoscopic study. J Rheumatol 22:680–683PubMed

Goel R, Danda D, Avinash B et al (2013) Clinico-pathological correlation of non specific inflammation in bowel histology with joint manifestation in a tertiary center in South India. Rheumatol Int 33:2149–2152. doi:10.1007/s00296-011-2332-x PubMedCrossRef

10.

Praet LV, den Bosch FEV, Jacques P et al (2013) Microscopic gut inflammation in axial spondyloarthritis: a multiparametric predictive model. Ann Rheum Dis 72:414–417. doi:10.1136/annrheumdis-2012-202135 PubMedCrossRef

11.

Praet LV, Jans L, Carron P et al (2014) Degree of bone marrow oedema in sacroiliac joints of patients with axial spondyloarthritis is linked to gut inflammation and male sex: results from the GIANT cohort. Ann Rheum Dis 73:1186–1189. doi:10.1136/annrheumdis-2013-203854 PubMedCrossRef

12.

Picco P, Gattorno M, Marchese N et al (2000) Increased gut permeability in juvenile chronic arthritides. A multivariate analysis of the diagnostic parameters. Clin Exp Rheumatol 18:773–778PubMed

13.

Mielants H, Veys EM, Cuvelier C et al (1993) Gut inflammation in children with late onset pauciarticular juvenile chronic arthritis and evolution to adult spondyloarthropathy—a prospective study. J Rheumatol 20:1567–1572PubMed

14.

Jacques P, Elewaut D (2008) Joint expedition: linking gut inflammation to arthritis. Mucosal Immunol 1:364–371. doi:10.1038/mi.2008.24 PubMedCrossRef

15.

Langhorst J, Wieder A, Michalsen A et al (2007) Activated innate immune system in irritable bowel syndrome? Gut 56:1325–1326. doi:10.1136/gut.2007.125005 PubMedPubMedCentralCrossRef

16.

Lin J-F, Chen J-M, Zuo J-H et al (2014) Meta-analysis: fecal calprotectin for assessment of inflammatory bowel disease activity. Inflamm Bowel Dis 20:1407–1415. doi:10.1097/MIB.0000000000000057 PubMedCrossRef

17.

Matzkies FG, Targan SR, Berel D et al (2012) Markers of intestinal inflammation in patients with ankylosing spondylitis: a pilot study. Arthritis Res Ther 14:R261. doi:10.1186/ar4106 PubMedPubMedCentralCrossRef

18.

Stoll ML, Punaro M, Patel AS (2011) Fecal calprotectin in children with the enthesitis-related arthritis subtype of juvenile idiopathic arthritis. J Rheumatol 38:2274–2275. doi:10.3899/jrheum.110508 PubMedPubMedCentralCrossRef

19.

Adams DH, Eksteen B (2006) Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease. Nat Rev Immunol 6:244–251. doi:10.1038/nri1784 PubMedCrossRef

20.

Johansson-Lindbom B, Agace WW (2007) Generation of gut-homing T cells and their localization to the small intestinal mucosa. Immunol Rev 215:226–242. doi:10.1111/j.1600-065X.2006.00482.x PubMedCrossRef

21.

Fantini M-C (2009) Common immunologic mechanisms in inflammatory bowel disease and spondyloarthropathies. World J Gastroenterol 15:2472. doi:10.3748/wjg.15.2472 PubMedPubMedCentralCrossRef

22.

Hindryckx P, Laukens D, Serry G et al (2011) Subclinical gut inflammation in spondyloarthritis is associated with a pro-angiogenic intestinal mucosal phenotype. Ann Rheum Dis 70:2044–2048. doi:10.1136/ard.2010.149229 PubMedCrossRef

23.

Salmi M, Rajala P, Jalkanen S (1997) Homing of mucosal leukocytes to joints. Distinct endothelial ligands in synovium mediate leukocyte-subtype specific adhesion. J Clin Invest 99:2165–2172PubMedPubMedCentralCrossRef

24.

May E, Märker-Hermann E, Wittig BM et al (2000) Identical T-cell expansions in the colon mucosa and the synovium of a patient with enterogenic spondyloarthropathy. Gastroenterology 119:1745–1755. doi:10.1053/gast.2000.20173 PubMedCrossRef

25.

Nagalingam NA, Kao JY, Young VB (2011) Microbial ecology of the murine gut associated with the development of dextran sodium sulfate-induced colitis. Inflamm Bowel Dis 17:917–926. doi:10.1002/ibd.21462 PubMedPubMedCentralCrossRef

26.

Dorofeyev AE, Vasilenko IV, Rassokhina OA et al (2013) Mucosal barrier in ulcerative colitis and Crohn’s disease. Gastroenterol Res Pract. doi:10.1155/2013/431231 PubMedPubMedCentral

27.

Heazlewood CK, Cook MC, Eri R et al (2008) Aberrant mucin assembly in mice causes endoplasmic reticulum stress and spontaneous inflammation resembling ulcerative colitis. PLoS Med 5:e54. doi:10.1371/journal.pmed.0050054 PubMedPubMedCentralCrossRef

28.

Ciccia F, Accardo-Palumbo A, Rizzo A et al (2014) Evidence that autophagy, but not the unfolded protein response, regulates the expression of IL-23 in the gut of patients with ankylosing spondylitis and subclinical gut inflammation. Ann Rheum Dis 73:1566–1574. doi:10.1136/annrheumdis-2012-202925 PubMedPubMedCentralCrossRef

29.

Ciccia F, Bombardieri M, Principato A et al (2009) Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis. Arthritis Rheum 60:955–965. doi:10.1002/art.24389 PubMedCrossRef

30.

Gheita TA, El Gazzar II, El-Fishawy HS et al (2014) Involvement of IL-23 in enteropathic arthritis patients with inflammatory bowel disease: preliminary results. Clin Rheumatol 33:713–717. doi:10.1007/s10067-013-2469-y PubMed

31.

Sherlock JP, Joyce-Shaikh B, Turner SP et al (2012) IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+ CD4−CD8− entheseal resident T cells. Nat Med 18:1069–1076. doi:10.1038/nm.2817 PubMedCrossRef

32.

Sutton CE, Lalor SJ, Sweeney CM et al (2009) Interleukin-1 and IL-23 induce innate IL-17 production from γδ T cells, amplifying Th17 responses and autoimmunity. Immunity 31:331–341. doi:10.1016/j.immuni.2009.08.001 PubMedCrossRef

33.

Costello M-E, Ciccia F, Willner D et al (2014) Intestinal dysbiosis in ankylosing spondylitis. Arthritis Rheumatol. doi:10.1002/art.38967 PubMed

34.

Poggi A, Zocchi MR (2014) NK cell autoreactivity and autoimmune diseases. Front Immunol 4(5):27. doi:10.3389/fimmu.2014.00027

35.

Walker JA, Barlow JL, McKenzie ANJ (2013) Innate lymphoid cells—how did we miss them? Nat Rev Immunol 13:75–87. doi:10.1038/nri3349 PubMedCrossRef

36.

Ciccia F, Accardo-Palumbo A, Giardina A et al (2010) Expansion of intestinal CD4+ CD25high Treg cells in patients with ankylosing spondylitis: a putative role for interleukin-10 in preventing intestinal Th17 response. Arthritis Rheum 62:3625–3634. doi:10.1002/art.27699 PubMedCrossRef

37.

Ciccia F, Accardo-Palumbo A, Alessandro R et al (2012) Interleukin-22 and interleukin-22-producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis. Arthritis Rheum 64:1869–1878. doi:10.1002/art.34355 PubMedCrossRef

38.

Takayama T, Kamada N, Chinen H et al (2010) Imbalance of NKp44(+)NKp46(−) and NKp44(−)NKp46(+) natural killer cells in the intestinal mucosa of patients with Crohn’s disease. Gastroenterology 139:882–892. doi:10.1053/j.gastro.2010.05.040 PubMedCrossRef

39.

Qiu J, Guo X, Chen ZE et al (2013) Group 3 innate lymphoid cells inhibit T-cell-mediated intestinal inflammation through aryl hydrocarbon receptor signaling and regulation of microflora. Immunity 39:386–399. doi:10.1016/j.immuni.2013.08.002 PubMedCrossRef

40.

Jr WO, Zenewicz LA, Flavell RA (2010) The dual nature of TH17 cells: shifting the focus to function. Nat Immunol 11:471–476. doi:10.1038/ni.1882 CrossRef

41.

Leung J, Davenport M, Wolff M et al (2014) IL-22-producing CD4+ cells are depleted in actively inflamed colitis tissue. Mucosal Immunol. doi:10.1038/mi.2013.31 PubMedPubMedCentral

42.

Sovran B, Loonen LMP, Lu P et al (2015) IL-22-STAT3 pathway plays a key role in the maintenance of ileal homeostasis in mice lacking secreted mucus barrier. Inflamm Bowel Dis. doi:10.1097/MIB.0000000000000319 PubMed

43.

Brand S (2009) Crohn’s disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn’s disease. Gut 58:1152–1167. doi:10.1136/gut.2008.163667 PubMedCrossRef

44.

Ciccia F, Guggino G, Rizzo A et al (2015) Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis. Ann Rheum Dis. doi:10.1136/annrheumdis-2014-206323 PubMed

45.

Cua DJ, Sherlock JP (2011) Autoimmunity’s collateral damage: gut microbiota strikes “back”. Nat Med 17:1055–1056. doi:10.1038/nm0911-1055 PubMedCrossRef

46.

Drummond RA, Saijo S, Iwakura Y, Brown GD (2011) The role of Syk/CARD9 coupled C-type lectins in antifungal immunity. Eur J Immunol 41:276–281. doi:10.1002/eji.201041252 PubMedPubMedCentralCrossRef

47.

Yoshitomi H, Sakaguchi N, Kobayashi K et al (2005) A role for fungal β-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice. J Exp Med 201:949–960. doi:10.1084/jem.20041758 PubMedPubMedCentralCrossRef

48.

Ruutu M, Thomas G, Steck R et al (2012) β-glucan triggers spondylarthritis and Crohn’s disease-like ileitis in SKG mice. Arthritis Rheum 64:2211–2222. doi:10.1002/art.34423 PubMedCrossRef

49.

Poeck H, Bscheider M, Gross O et al (2010) Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1 beta production. Nat Immunol 11:63–69. doi:10.1038/ni.1824 PubMedCrossRef

50.

Sokol H, Conway KL, Zhang M et al (2013) Card9 mediates intestinal epithelial cell restitution, T-helper 17 responses, and control of bacterial infection in mice. Gastroenterology 145(591–601):e3. doi:10.1053/j.gastro.2013.05.047 PubMed

51.

Ley RE, Peterson DA, Gordon JI (2006) Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124:837–848. doi:10.1016/j.cell.2006.02.017 PubMedCrossRef

52.

Qin J, Li R, Raes J et al (2010) A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464:59–65. doi:10.1038/nature08821 PubMedPubMedCentralCrossRef

53.

O’Hara AM, Shanahan F (2006) The gut flora as a forgotten organ. EMBO Rep 7:688–693. doi:10.1038/sj.embor.7400731 PubMedPubMedCentralCrossRef

54.

Rastall RA (2004) Bacteria in the gut: friends and foes and how to alter the balance. J Nutr 134:2022S–2026SPubMed

55.

Kostic AD, Howitt MR, Garrett WS (2013) Exploring host–microbiota interactions in animal models and humans. Genes Dev 27:701–718. doi:10.1101/gad.212522.112 PubMedPubMedCentralCrossRef

56.

Guarner F, Malagelada J-R (2003) Gut flora in health and disease. The Lancet 361:512–519. doi:10.1016/S0140-6736(03)12489-0 CrossRef

57.

Hammer RE, Maika SD, Richardson JA et al (1990) Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human β2m: an animal model of HLA-B27-associated human disorders. Cell 63:1099–1112. doi:10.1016/0092-8674(90)90512-D PubMedCrossRef

58.

Taurog JD, Richardson JA, Croft JT et al (1994) The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med 180:2359–2364PubMedCrossRef

59.

Rath HC, Herfarth HH, Ikeda JS et al (1996) Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats. J Clin Invest 98:945–953. doi:10.1172/JCI118878 PubMedPubMedCentralCrossRef

60.

McBurney W, Mangold M, Munro K et al (2006) PCR/DGGE and 16S rRNA gene library analysis of the colonic microbiota of HLA-B27/beta2-microglobulin transgenic rats. Lett Appl Microbiol 42:165–171. doi:10.1111/j.1472-765X.2005.01811.x PubMedCrossRef

61.

Onderdonk AB, Richardson JA, Hammer RE, Taurog JD (1998) Correlation of cecal microflora of HLA-B27 transgenic rats with inflammatory bowel disease. Infect Immun 66:6022–6023PubMedPubMedCentral

62.

Hacquard-Bouder C, Ittah M, Breban M (2006) Animal models of HLA-B27-associated diseases: new outcomes. Jt Bone Spine Rev Rhum 73:132–138. doi:10.1016/j.jbspin.2005.03.016 CrossRef

63.

Lin P, Bach M, Asquith M et al (2014) HLA-B27 and human β2-microglobulin affect the gut microbiota of transgenic rats. PLoS One 9(8):105684. doi:10.1371/journal.pone.0105684 CrossRef

64.

Rath HC (2002) Role of commensal bacteria in chronic experimental colitis: lessons from the HLA-B27 transgenic rat. Pathobiol J Immunopathol Mol Cell Biol 70:131–138CrossRef

65.

Png CW, Lindén SK, Gilshenan KS et al (2010) Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am J Gastroenterol 105:2420–2428. doi:10.1038/ajg.2010.281 PubMedCrossRef

66.

Reháková Z, Capková J, Stĕpánková R et al (2000) Germ-free mice do not develop ankylosing enthesopathy, a spontaneous joint disease. Hum Immunol 61:555–558PubMedCrossRef

67.

Sinkorová Z, Capková J, Niederlová J et al (2008) Commensal intestinal bacterial strains trigger ankylosing enthesopathy of the ankle in inbred B10.BR (H-2(k)) male mice. Hum Immunol 69:845–850. doi:10.1016/j.humimm.2008.08.296 PubMedCrossRef

68.

Rosenbaum JT, Davey MP (2011) Time for a gut check: evidence for the hypothesis that HLA–B27 predisposes to ankylosing spondylitis by altering the microbiome. Arthritis Rheum 63:3195–3198. doi:10.1002/art.30558 PubMedPubMedCentralCrossRef

69.

Firestein GS (2004) The T cell cometh: interplay between adaptive immunity and cytokine networks in rheumatoid arthritis. J Clin Invest 114:471–474. doi:10.1172/JCI22651 PubMedPubMedCentralCrossRef

70.

Sakaguchi S, Takahashi T, Hata H et al (2006) SKG mice, a monogenic model of autoimmune arthritis due to altered signal transduction in T-cells. In: Holmdahl R (ed) Hered. Basis Rheum. Dis. Birkhäuser Basel, pp 147–159

71.

Sakaguchi N, Takahashi T, Hata H et al (2003) Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature 426:454–460. doi:10.1038/nature02119 PubMedCrossRef

72.

Benham H, Rehaume LM, Hasnain SZ et al (2014) Interleukin-23 mediates the intestinal response to microbial β-1,3-glucan and the development of spondyloarthritis pathology in SKG mice. Arthritis Rheumatol Hoboken NJ 66:1755–1767. doi:10.1002/art.38638 CrossRef

73.

Akramiene D, Kondrotas A, Didziapetriene J, Kevelaitis E (2007) Effects of beta-glucans on the immune system. Med Kaunas Lith 43:597–606

74.

Rehaume LM, Mondot S, Aguirre de Cárcer D et al (2014) ZAP-70 genotype disrupts the relationship between microbiota and host, leading to spondyloarthritis and ileitis in SKG mice. Arthritis Rheumatol Hoboken NJ 66:2780–2792. doi:10.1002/art.38773 CrossRef

75.

Ganner A, Schatzmayr G (2012) Capability of yeast derivatives to adhere enteropathogenic bacteria and to modulate cells of the innate immune system. Appl Microbiol Biotechnol 95:289–297. doi:10.1007/s00253-012-4140-y PubMedCrossRef

76.

Stebbings S, Munro K, Simon MA et al (2002) Comparison of the faecal microflora of patients with ankylosing spondylitis and controls using molecular methods of analysis. Rheumatol Oxf Engl 41:1395–1401CrossRef

77.

Rashid T, Wilson C, Ebringer A (2013) The link between ankylosing spondylitis, Crohn’s disease, Klebsiella, and starch consumption. Clin Dev Immunol. doi:10.1155/2013/872632 PubMedPubMedCentral

78.

Ebringer A, Wilson C (1996) The use of a low starch diet in the treatment of patients suffering from ankylosing spondylitis. Clin Rheumatol 15(Suppl 1):62–66PubMedCrossRef

79.

Rashid T, Ebringer A (2011) Gut-mediated and HLA-B27-associated arthritis: an emphasis on ankylosing spondylitis and Crohn’s disease with a proposal for the use of new treatment. Discov Med 12:187–194PubMed

80.

Stone MA, Payne U, Schentag C et al (2004) Comparative immune responses to candidate arthritogenic bacteria do not confirm a dominant role for Klebsiella pneumonia in the pathogenesis of familial ankylosing spondylitis. Rheumatol Oxf Engl 43:148–155. doi:10.1093/rheumatology/keg482 CrossRef

81.

Aydin SZ, Atagunduz P, Temel M et al (2008) Anti-Saccharomyces cerevisiae antibodies (ASCA) in spondyloarthropathies: a reassessment. Rheumatology 47:142–144. doi:10.1093/rheumatology/kem324 PubMedCrossRef

82.

Wallis D, Asaduzzaman A, Weisman M et al (2013) Elevated serum anti-flagellin antibodies implicate subclinical bowel inflammation in ankylosing spondylitis: an observational study. Arthritis Res Ther 15:R166. doi:10.1186/ar4350 PubMedPubMedCentralCrossRef

83.

Mundwiler ML, Mei L, Landers CJ et al (2009) Inflammatory bowel disease serologies in ankylosing spondylitis patients: a pilot study. Arthritis Res Ther 11:R177. doi:10.1186/ar2866 PubMedPubMedCentralCrossRef

84.

Kabeerdoss J, Jayakanthan P, Pugazhendhi S, Ramakrishna BS (2015) Alterations of mucosal microbiota in the colon of patients with inflammatory bowel disease revealed by real time polymerase chain reaction amplification of 16S ribosomal ribonucleic acid. Indian J Med Res 142:23–32. doi:10.4103/0971-5916.162091 PubMedPubMedCentral

85.

Scher JU, Ubeda C, Artacho A et al (2015) Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease. Arthritis Rheumatol Hoboken NJ 67:128–139. doi:10.1002/art.38892 CrossRef

86.

Colmegna I, Cuchacovich R, Espinoza LR (2004) HLA-B27-associated reactive arthritis: pathogenetic and clinical considerations. Clin Microbiol Rev 17:348–369. doi:10.1128/CMR.17.2.348-369.2004 PubMedPubMedCentralCrossRef

87.

Siala M, Jaulhac B, Gdoura R et al (2008) Analysis of bacterial DNA in synovial tissue of Tunisian patients with reactive and undifferentiated arthritis by broad-range PCR, cloning and sequencing. Arthritis Res Ther 10:R40. doi:10.1186/ar2398 PubMedPubMedCentralCrossRef

88.

Siala M, Gdoura R, Fourati H et al (2009) Broad-range PCR, cloning and sequencing of the full 16S rRNA gene for detection of bacterial DNA in synovial fluid samples of Tunisian patients with reactive and undifferentiated arthritis. Arthritis Res Ther 11:R102. doi:10.1186/ar2748 PubMedPubMedCentralCrossRef

89.

Dorofeyev AE, Vasilenko IV, Rassokhina OA (2009) Joint extraintestinal manifestations in ulcerative colitis. Dig Dis Basel Switz 27:502–510. doi:10.1159/000233289 CrossRef

90.

(2014) Poster Sessions. FEBS J 281:65–784. doi:10.1111/febs.12919

91.

Malin M, Verronen P, Mykkänen H et al (1996) Increased bacterial urease activity in faeces in juvenile chronic arthritis: evidence of altered intestinal microflora? Rheumatology 35:689–694. doi:10.1093/rheumatology/35.7.689 CrossRef

92.

Stoll ML, Kumar R, Morrow CD et al (2014) Altered microbiota associated with abnormal humoral immune responses to commensal organisms in enthesitis-related arthritis. Arthritis Res Ther 16:486. doi:10.1186/s13075-014-0486-0 PubMedPubMedCentralCrossRef

93.

Baharav E, Mor F, Halpern M, Weinberger A (2004) Lactobacillus GG bacteria ameliorate arthritis in lewis rats. J Nutr 134:1964–1969PubMed

94.

Noto Llana M, Sarnacki SH, Castañeda MDRA et al (2013) Consumption of Lactobacillus casei fermented milk prevents Salmonella reactive arthritis by modulating IL-23/IL-17 expression. PLoS One 8:e82588. doi:10.1371/journal.pone.0082588 PubMedPubMedCentralCrossRef

95.

Magrone T, Jirillo E (2014) The interleukin-17/interleukin-22 innate axis in the gut as a new drug target in allergic-inflammatory and autoimmune diseases. A working hypothesis. Endocr Metab Immune Disord Drug Targets 14:145–151PubMedCrossRef

96.

Schultz M, Munro K, Tannock GW et al (2004) Effects of feeding a probiotic preparation (SIM) containing inulin on the severity of colitis and on the composition of the intestinal microflora in HLA-B27 transgenic rats. Clin Diagn Lab Immunol 11:581–587. doi:10.1128/CDLI.11.3.581-587.2004 PubMedPubMedCentral

97.

Dieleman LA, Goerres MS, Arends A et al (2003) Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment. Gut 52:370–376PubMedPubMedCentralCrossRef

98.

Jenks K, Stebbings S, Burton J et al (2010) Probiotic therapy for the treatment of spondyloarthritis: a randomized controlled trial. J Rheumatol 37:2118–2125. doi:10.3899/jrheum.100193 PubMedCrossRef

99.

Brophy S, Burrows CL, Brooks C et al (2008) Internet-based randomised controlled trials for the evaluation of complementary and alternative medicines: probiotics in spondyloarthropathy. BMC Musculoskelet Disord 9:4. doi:10.1186/1471-2474-9-4 PubMedPubMedCentralCrossRef

100.

Sanges M, Valente G, Rea M et al (2009) Probiotics in spondyloarthropathy associated with ulcerative colitis: a pilot study. Eur Rev Med Pharmacol Sci 13:233–234PubMed

101.

Pineiro M, Asp N-G, Reid G et al (2008) FAO technical meeting on prebiotics. J Clin Gastroenterol 42:S156–S159. doi:10.1097/MCG.0b013e31817f184e PubMedCrossRef

102.

Kleessen B, Hartmann L, Blaut M (2001) Oligofructose and long-chain inulin: influence on the gut microbial ecology of rats associated with a human faecal flora. Br J Nutr 86:291–300PubMedCrossRef

103.

Kim CH, Park J, Kim M (2014) Gut microbiota-derived short-chain fatty acids, T cells, and inflammation. Immune Netw 14:277–288. doi:10.4110/in.2014.14.6.277 PubMedPubMedCentralCrossRef

104.

Casellas F, Borruel N, Torrejón A et al (2007) Oral oligofructose-enriched inulin supplementation in acute ulcerative colitis is well tolerated and associated with lowered faecal calprotectin. Aliment Pharmacol Ther 25:1061–1067. doi:10.1111/j.1365-2036.2007.03288.x PubMedCrossRef

105.

Kanauchi O, Suga T, Tochihara M et al (2013) Treatment of ulcerative colitis by feeding with germinated barley foodstuff: first report of a multicenter open control trial. J Gastroenterol 37:67–72. doi:10.1007/BF03326417 CrossRef

106.

Scaldaferri F, Gerardi V, Lopetuso LR et al (2013) Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility. BioMed Res Int 2013:e435268. doi:10.1155/2013/435268 CrossRef

107.

Hoentjen F, Welling GW, Harmsen HJM et al (2005) Reduction of colitis by prebiotics in HLA-B27 transgenic rats is associated with microflora changes and immunomodulation. Inflamm Bowel Dis 11:977–985PubMedCrossRef

108.

Koleva P, Ketabi A, Valcheva R et al (2014) Chemically defined diet alters the protective properties of fructo-oligosaccharides and isomalto-oligosaccharides in HLA-B27 transgenic rats. PLoS One 9:e111717. doi:10.1371/journal.pone.0111717 PubMedPubMedCentralCrossRef

109.

Barber CE, Kim J, Inman RD et al (2013) Antibiotics for treatment of reactive arthritis: a systematic review and metaanalysis. J Rheumatol 40:916–928. doi:10.3899/jrheum.121192 PubMedCrossRef

110.

Carter JD, Espinoza LR, Inman RD et al (2010) Combination antibiotics as a treatment for chronic Chlamydia-induced reactive arthritis: a double-blind, placebo-controlled, prospective trial. Arthritis Rheum 62:1298–1307. doi:10.1002/art.27394 PubMedPubMedCentralCrossRef

111.

Frydén A, Bengtsson A, Foberg U et al (1990) Early antibiotic treatment of reactive arthritis associated with enteric infections: clinical and serological study. BMJ 301:1299–1302PubMedPubMedCentralCrossRef

112.

Rohekar S, Chan J, Tse SML et al (2015) 2014 Update of the Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada Treatment Recommendations for the management of spondyloarthritis. Part II: specific management recommendations. J Rheumatol 42:654–664. doi:10.3899/jrheum.141001 PubMedCrossRef

113.

Bakken JS, Borody T, Brandt LJ et al (2011) Treating clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol 9:1044–1049. doi:10.1016/j.cgh.2011.08.014 PubMedPubMedCentralCrossRef

114.

Eiseman B, Silen W, Bascom GS, Kauvar AJ (1958) Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 44:854–859PubMed

115.

van Nood E, Vrieze A, Nieuwdorp M et al (2013) Duodenal infusion of donor feces for recurrent clostridium difficile. N Engl J Med 368:407–415. doi:10.1056/NEJMoa1205037 PubMedCrossRef

116.

Smith MB, Kelly C, Alm EJ (2014) Policy: how to regulate faecal transplants. Nature 506:290–291PubMedCrossRef

117.

Colman RJ, Rubin DT (2014) Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis. J Crohns Colitis 8:1569–1581. doi:10.1016/j.crohns.2014.08.006 PubMedPubMedCentralCrossRef

118.

Anderson CA, Boucher G, Lees CW et al (2011) Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet 43:246–252. doi:10.1038/ng.764 PubMedPubMedCentralCrossRef

119.

McGovern DPB, Gardet A, Törkvist L et al (2010) Genome-wide association identifies multiple ulcerative colitis susceptibility loci. Nat Genet 42:332–337. doi:10.1038/ng.549 PubMedPubMedCentralCrossRef

120.

Uk, IBD Genetics Consortium, Barrett JC, Lee JC et al (2009) Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region. Nat Genet 41:1330–1334. doi:10.1038/ng.483 CrossRef

121.

Julià A, Domènech E, Ricart E et al (2013) A genome-wide association study on a southern European population identifies a new Crohn’s disease susceptibility locus at RBX1-EP300. Gut 62:1440–1445. doi:10.1136/gutjnl-2012-302865 PubMedCrossRef

122.

Franke A, McGovern DPB, Barrett JC et al (2010) Genome-wide meta-analysis increases to 71 the number of confirmed Crohn’s disease susceptibility loci. Nat Genet 42:1118–1125. doi:10.1038/ng.717 PubMedPubMedCentralCrossRef

123.

Evans DM, Spencer CCA, Pointon JJ et al (2011) Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet 43:761–767. doi:10.1038/ng.873 PubMedPubMedCentralCrossRef

124.

Wellcome Trust Case Control Consortium (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447:661–678. doi:10.1038/nature05911 CrossRef

125.

Australo-Anglo-American Spondyloarthritis Consortium (TASC), Reveille JD, Sims A-M et al (2010) Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat Genet 42:123–127. doi:10.1038/ng.513 CrossRef

126.

Barrett JC, Hansoul S, Nicolae DL et al (2008) Genome-wide association defines more than 30 distinct susceptibility loci for Crohn’s disease. Nat Genet 40:955–962. doi:10.1038/ng.175 PubMedPubMedCentralCrossRef

127.

Kugathasan S, Baldassano RN, Bradfield JP et al (2008) Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease. Nat Genet 40:1211–1215. doi:10.1038/ng.203 PubMedPubMedCentralCrossRef

128.

Jostins L, Ripke S, Weersma RK et al (2012) Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491:119–124. doi:10.1038/nature11582 PubMedPubMedCentralCrossRef

129.

Parkes M, Barrett JC, Prescott NJ et al (2007) Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn’s disease susceptibility. Nat Genet 39:830–832. doi:10.1038/ng2061 PubMedPubMedCentralCrossRef

130.

Libioulle C, Louis E, Hansoul S et al (2007) Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. PLoS Genet 3:e58. doi:10.1371/journal.pgen.0030058 PubMedPubMedCentralCrossRef

131.

Hüffmeier U, Uebe S, Ekici AB et al (2010) Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis. Nat Genet 42:996–999. doi:10.1038/ng.688 PubMedPubMedCentralCrossRef

132.

Haritunians T, Taylor KD, Targan SR et al (2010) Genetic predictors of medically refractory ulcerative colitis. Inflamm Bowel Dis 16:1830–1840. doi:10.1002/ibd.21293 PubMedPubMedCentralCrossRef

133.

Silverberg MS, Cho JH, Rioux JD et al (2009) Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study. Nat Genet 41:216–220. doi:10.1038/ng.275 PubMedPubMedCentralCrossRef

134.

Yang S-K, Hong M, Zhao W et al (2014) Genome-wide association study of Crohn’s disease in Koreans revealed three new susceptibility loci and common attributes of genetic susceptibility across ethnic populations. Gut 63:80–87. doi:10.1136/gutjnl-2013-305193 PubMedCrossRef

135.

Yamazaki K, Umeno J, Takahashi A et al (2013) A genome-wide association study identifies 2 susceptibility loci for Crohn’s disease in a Japanese population. Gastroenterology 144:781–788. doi:10.1053/j.gastro.2012.12.021 PubMedCrossRef

136.

Kenny EE, Pe’er I, Karban A et al (2012) A genome-wide scan of Ashkenazi Jewish Crohn’s disease suggests novel susceptibility loci. PLoS Genet 8:e1002559. doi:10.1371/journal.pgen.1002559 PubMedPubMedCentralCrossRef

137.

Okada Y, Yamazaki K, Umeno J et al (2011) HLA-Cw*1202-B*5201-DRB1*1502 haplotype increases risk for ulcerative colitis but reduces risk for Crohn’s disease. Gastroenterology 141:864–871. doi:10.1053/j.gastro.2011.05.048 PubMedCrossRef

Titel: Gut inflammation and microbiome in spondyloarthritis
verfasst von: Jayakanthan Kabeerdoss
Pulukool Sandhya
Debashish Danda
Publikationsdatum: 01.04.2016
Verlag: Springer Berlin Heidelberg
Erschienen in: Rheumatology International / Ausgabe 4/2016
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-015-3414-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2016

Pro-brain natriuretic peptide (ProBNP) levels in North Indian children with Kawasaki disease

The IL-33 gene is related to increased susceptibility to systemic sclerosis

Anti-DNase I antibodies in systemic lupus erythematosus: diagnostic value and share in the enzyme inhibition

Cross-cultural validation of the paediatric Gait, Arms, Legs, Spine (pGALS) tool for the screening of musculoskeletal disorders in Mexican children

TLR9 polymorphisms and systemic lupus erythematosus risk: an update meta-analysis study